Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
PUT
S&P Global
SPGI
$127B
| $7.37M | 0.01% |
+35,000
| New | +$6.78M |
|
|
K
1477
DELISTED
Kellanova
K
| $7.37M | 0.01% |
136,732
-131,375
| -49% | -$7.01M |
|
|
RST
1478
DELISTED
ROSETTA STONE INC
RST
| $7.35M | 0.01% |
336,480
+111,717
| +50% | +$1.95M |
|
1479
Universal Display
OLED
$3.97B
| $7.33M | 0.01% |
+47,973
| New | +$5.94M |
|
|
AGN
1480
CALL
DELISTED
Allergan plc
AGN
| $7.32M | 0.01% |
+50,000
| New | +$7.25M |
|
|
BEST
1481
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $7.32M | 0.01% |
69,929
+65,297
| +1,410% | +$6.81M |
|
1482
Terex
TEX
$7.46B
| $7.31M | 0.01% |
+227,575
| New | +$7.22M |
|
1483
Corcept Therapeutics
CORT
$13.3B
| $7.3M | 0.01% |
622,273
-46,564
| -7% | -$579K |
|
1484
CALL
LivaNova
LIVN
$4.35B
| $7.29M | 0.01% |
+75,000
| New | +$7M |
|
1485
Apple Hospitality REIT
APLE
$3.95B
| $7.29M | 0.01% |
446,968
-355,162
| -44% | -$5.69M |
|
|
JAG
1486
DELISTED
Jagged Peak Energy Inc.
JAG
| $7.26M | 0.01% |
693,786
+646,504
| +1,367% | +$6.68M |
|
1487
PUT
Charles River Laboratories
CRL
$14.2B
| $7.26M | 0.01% |
50,000
+45,000
| +900% | +$5.91M |
|
|
MFA
1488
MFA Financial
MFA
$892M
| $7.25M | 0.01% |
249,375
+103,721
| +71% | +$3M |
|
1489
Minerva Neurosciences
NERV
$245M
| $7.25M | 0.01% |
115,316
-41,144
| -26% | -$2.47M |
|
|
IPHI
1490
DELISTED
INPHI CORPORATION
IPHI
| $7.25M | 0.01% |
165,685
+143,011
| +631% | +$5.69M |
|
|
ADMS
1491
DELISTED
Adamas Pharmaceuticals
ADMS
| $7.24M | 0.01% |
1,017,983
+538,084
| +112% | +$4.84M |
|
1492
AeroVironment
AVAV
$7.55B
| $7.24M | 0.01% |
105,795
+81,436
| +334% | +$6.14M |
|
1493
CALL
Cigna
CI
$73.5B
| $7.24M | 0.01% |
+45,000
| New | +$8.22M |
|
|
SFIX
1494
Stitch Fix
SFIX
$430M
| $7.2M | 0.01% |
255,016
+123,421
| +94% | +$3.07M |
|
1495
Parker-Hannifin
PH
$128B
| $7.18M | 0.01% |
41,857
-25,133
| -38% | -$4.17M |
|
1496
PUT
ExxonMobil
XOM
$665B
| $7.17M | 0.01% |
+88,800
| New | +$6.77M |
|
1497
Performance Food Group
PFGC
$16.4B
| $7.17M | 0.01% |
180,883
-529,664
| -75% | -$19.4M |
|
1498
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46B
| $7.14M | 0.01% |
27,550
-23,923
| -46% | -$6.02M |
|
|
CMTA
1499
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $7.13M | 0.01% |
273,286
+248,426
| +999% | +$4.64M |
|
1500
ASML
ASML
$671B
| $7.12M | 0.01% |
37,856
-2,794
| -7% | -$495K |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.